Fresenius Delayed By FDA Inspection Uncertainty As It Works Towards US Pegfilgrastim Launch
Biosimilars Head Ali Ahmed Talks About Company’s Biosimilars Strategy
• By Akriti Seth
Ahmed said the upcoming pegfilgrastim launch was “an important milestone for the company” • Source: Fresenius Kabi 
